Presence and prevalence of salivary gland ectasia and oral disease in COVID-19 survivors

COVID-19, coronavirus
This scanning electron microscope image shows SARS-CoV-2 (yellow)—also known as 2019-nCoV, the virus that causes COVID-19—isolated from a patient, emerging from the surface of cells (blue/pink) cultured in the lab. Credit: NIAID-RML

The clinical picture of COVID-19 in various target organs has been extensively studied and described, but relatively little is known about the characteristics of oral cavity involvement. The study "Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19" published in the Journal of Dental Research (JDR), investigated the presence and prevalence of oral manifestations in COVID-19 survivors.

Researchers at the Università Vita Salute San Raffaele, Milan, Italy, profiled the oral involvement in 122 COVID-19 survivors, hospitalized and followed up at a single referral visit after a median 104 days from hospital discharge. The researchers found that oral manifestations, specifically salivary gland ectasia, were unexpectedly common being detectable in 83.9% and 43% of COVID-19 survivors, respectively. Salivary glands were defined as being ectasic when they appeared swollen, with a patent duct, and no pus leaking. Salivary gland ectasia reflected the hyperinflammatory response to SARS-CoV-2, as demonstrated by the with C-reactive protein and lactate dehydrogenase (LDH) levels at hospital admission, and with the use of antibiotics during acute disease. Both LDH levels and antibiotic administration survived as independent predictors of salivary ectasia in a multivariable analysis. Temporomandibular joint abnormalities, facial pain and masticatory muscle weakness were also common.

"This retrospective and prospective cohort study of COVID-19 survivors revealed that residual damage of the oral cavity persists in the vast majority of the more severely affected patients far beyond clinical recovery," said JDR Editor-in-Chief Nicholas Jakubovics, Newcastle University, England. "This suggests that the represents a preferential target for SARS-CoV-2 infection. Further studies are needed to clarify the connection between SARS-CoV-2 infection and oral disorders."


Explore further

Essential oral healthcare during the COVID-19 pandemic

More information: E.F. Gherlone et al, Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19, Journal of Dental Research (2021). DOI: 10.1177/0022034521997112
Journal information: Journal of Dental Research

Provided by International & American Associations for Dental Research
Citation: Presence and prevalence of salivary gland ectasia and oral disease in COVID-19 survivors (2021, March 3) retrieved 14 April 2021 from https://medicalxpress.com/news/2021-03-presence-prevalence-salivary-gland-ectasia.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
7 shares

Feedback to editors

User comments